Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page now shows a 403 Forbidden error page instead of the study details, with a simple header and a Home link, plus a revision tag indicating an update.SummaryDifference18%

- Check13 days agoChange DetectedThe MedlinePlus related topics section now includes entries for 'Ovarian cancer' and 'MedlinePlus Genetics', expanding the disease context and linked genetics resources.SummaryDifference0.2%

- Check20 days agoChange DetectedRemoval of the ovarian cancer term and a linked genetics resource from the page's related topics section. This affects topic tagging and cross-references, potentially impacting discoverability for ovarian cancer content.SummaryDifference0.2%

- Check27 days agoChange DetectedAdds NIH grant/contract note (2018), mentions ovarian cancer and related topics (MedlinePlus Genetics), and updates the site revision to v3.6.6 to reflect a newer release.SummaryDifference0.3%

- Check34 days agoChange DetectedRelated topics links for Ovarian cancer and MedlinePlus Genetics were removed from the page's related topics section, reducing external resource navigation.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded 'Ovarian cancer' as a keyword/related topic and linked MedlinePlus Genetics, and updated the site release version from v3.6.4 to v3.6.5.SummaryDifference0.2%

Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.